Seungil Kim
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Seungil Kim has a total of 118 co-authors. Here are the top co-authors by number of shared publications:
- William R. Wagner
Department of Bioengineering University of Pittsburgh Pittsburgh Pennsylvania USA
10 shared publications Jin Ik Lim
Korea Institute of Science and Technology
6 shared publications- Soo Hyun Kim
KU-KIST Graduate School of Converging Science and Technology, Korea University, 145 Anam-ro, Seongbuk-gu, Seoul 02841, Republic of Korea
6 shared publications - Song Liu
Department of Biosystems Engineering, University of Manitoba, Winnipeg, Manitoba, Canada
5 shared publications Youngmee Jung
Korea Institute of Science and Technology
4 shared publicationsCatherine Cao
Department of Neurosurgery, University of Pittsburgh Medical Center
3 shared publications
Latest Publications
- Open Access
- 21 October 2026
- Published by Wiley in Journal of Biomedical Materials Research Part A
- Vol. 114 (11)
An Ascorbic‐Acid Containing Poly(Carbonate) Urethane With Antioxidant Bioactivity for Application in Heart Valve Scaffold Development
Prosthetic heart valve development consists of several branching, innovative strategies to mediate the complex native environment that wears down valve durability. Anti‐calcification treatments are being applied to pericardial tissue, durable polymers are being developed that mitigate oxidative degradation and stress cracking, and heart valve tissue engineering has introduced resorbable scaffolds that can develop into stable, functional tissue. In each case, an increasing breadth of strategies is being developed to curb the persistent issue of valve deterioration. This study aimed to synthesize and characterize an ascorbic acid‐containing polyurethane to impart antioxidant properties to degradable scaffolds for tissue engineered heart valve (TEHV) replacement. Blends of poly(carbonate‐ascorbic acid) urethane (PCAU) and poly(carbonate urethane) urea (PCUU) were fabricated into microporous scaffolds to evaluate the impact of PCAU in vitro on mechanics, degradation, cell viability, calcification, bacterial adhesion, and in vivo on native tissue response in a juvenile rat subcutaneous model. PCAU blended with PCUU in a 25:75 ratio (PCAU‐25) had mechanical properties similar to PCUU, while higher concentrations of PCAU were not mechanically robust. PCAU‐25 showed greater reactive oxygen species (ROS) inhibition and degradation, and reduced calcification and bacterial adhesion in vitro. In a juvenile rat subcutaneous model, both PCUU and PCAU‐25 groups showed negligible calcification after 4 weeks. PCAU‐25, however, showed much greater cell infiltration and immune response, possibly due to an accelerated rate of degradation. PCAU‐25 was then fabricated into a polymeric valve scaffold and underwent basic mechanical and hydrodynamic performance assessment that demonstrated function similar to PCUU valves previously reported. These findings demonstrate proof‐of‐concept for a new polyurethane formulation incorporating ascorbic acid for antioxidant bioactivity and translatability into a functional TEHV scaffold.
- 21 October 2026
- Published by Wiley in Journal of Biomedical Materials Research Part A
- Vol. 114 (11)
Open AccessAn Ascorbic‐Acid Containing Poly(Carbonate) Urethane With Antioxidant Bioactivity for Application in Heart Valve Scaffold Development
Prosthetic heart valve development consists of several branching, innovative strategies to mediate the complex native environment that wears down valve durability. Anti‐calcification treatments are being applied to pericardial tissue, durable polymers are being developed that mitigate oxidative degradation and stress cracking, and heart valve tissue engineering has introduced resorbable scaffolds that can develop into stable, functional tissue. In each case, an increasing breadth of strategies is being developed to curb the persistent issue of valve deterioration. This study aimed to synthesize and characterize an ascorbic acid‐containing polyurethane to impart antioxidant properties to degradable scaffolds for tissue engineered heart valve (TEHV) replacement. Blends of poly(carbonate‐ascorbic acid) urethane (PCAU) and poly(carbonate urethane) urea (PCUU) were fabricated into microporous scaffolds to evaluate the impact of PCAU in vitro on mechanics, degradation, cell viability, calcification, bacterial adhesion, and in vivo on native tissue response in a juvenile rat subcutaneous model. PCAU blended with PCUU in a 25:75 ratio (PCAU‐25) had mechanical properties similar to PCUU, while higher concentrations of PCAU were not mechanically robust. PCAU‐25 showed greater reactive oxygen species (ROS) inhibition and degradation, and reduced calcification and bacterial adhesion in vitro. In a juvenile rat subcutaneous model, both PCUU and PCAU‐25 groups showed negligible calcification after 4 weeks. PCAU‐25, however, showed much greater cell infiltration and immune response, possibly due to an accelerated rate of degradation. PCAU‐25 was then fabricated into a polymeric valve scaffold and underwent basic mechanical and hydrodynamic performance assessment that demonstrated function similar to PCUU valves previously reported. These findings demonstrate proof‐of‐concept for a new polyurethane formulation incorporating ascorbic acid for antioxidant bioactivity and translatability into a functional TEHV scaffold.
- 9 September 2025
- Published by MyJove Corporation
- No. 223,p. e67872
JoVE Video Dataset
Cerebral aneurysms are present in approximately 2%-5% of the population and represent a significant public health concern due to their high rates of mortality and morbidity upon rupture. Despite advancements in research, the development of effective and reproducible animal models remains a challenge. Among the available models, surgically induced aneurysms are widely utilized; however, the technical complexity of these procedures often limits their accessibility. These methods require extensive surgical expertise and are associated with higher rates of intraoperative mortality or inconsistent aneurysm formation, which can compromise the reliability of experimental outcomes. To address these limitations, this video article introduces a simplified surgical procedure for inducing carotid aneurysms in mice, performed in a single session. This streamlined approach has demonstrated an impressive 87% success rate in inducing carotid aneurysms in female mice. By reducing technical challenges and improving reproducibility, this method provides a practical and reliable alternative for cerebral aneurysm research. Its widespread adoption could facilitate standardized studies, accelerate the development of therapeutic strategies, and ultimately advance our understanding of aneurysm pathophysiology.
- 9 September 2025
- Published by MyJove Corporation
- No. 223,p. e67872
JoVE Video Dataset
Cerebral aneurysms are present in approximately 2%-5% of the population and represent a significant public health concern due to their high rates of mortality and morbidity upon rupture. Despite advancements in research, the development of effective and reproducible animal models remains a challenge. Among the available models, surgically induced aneurysms are widely utilized; however, the technical complexity of these procedures often limits their accessibility. These methods require extensive surgical expertise and are associated with higher rates of intraoperative mortality or inconsistent aneurysm formation, which can compromise the reliability of experimental outcomes. To address these limitations, this video article introduces a simplified surgical procedure for inducing carotid aneurysms in mice, performed in a single session. This streamlined approach has demonstrated an impressive 87% success rate in inducing carotid aneurysms in female mice. By reducing technical challenges and improving reproducibility, this method provides a practical and reliable alternative for cerebral aneurysm research. Its widespread adoption could facilitate standardized studies, accelerate the development of therapeutic strategies, and ultimately advance our understanding of aneurysm pathophysiology.
- 9 September 2025
- Published by MyJove Corporation in Journal of Visualized Experiments
- No. 223,p. e67872
A Murine Model of Carotid Aneurysm Formation
Cerebral aneurysms are present in approximately 2%-5% of the population and represent a significant public health concern due to their high rates of mortality and morbidity upon rupture. Despite advancements in research, the development of effective and reproducible animal models remains a challenge. Among the available models, surgically induced aneurysms are widely utilized; however, the technical complexity of these procedures often limits their accessibility. These methods require extensive surgical expertise and are associated with higher rates of intraoperative mortality or inconsistent aneurysm formation, which can compromise the reliability of experimental outcomes. To address these limitations, this video article introduces a simplified surgical procedure for inducing carotid aneurysms in mice, performed in a single session. This streamlined approach has demonstrated an impressive 87% success rate in inducing carotid aneurysms in female mice. By reducing technical challenges and improving reproducibility, this method provides a practical and reliable alternative for cerebral aneurysm research. Its widespread adoption could facilitate standardized studies, accelerate the development of therapeutic strategies, and ultimately advance our understanding of aneurysm pathophysiology.
- 9 September 2025
- Published by MyJove Corporation in Journal of Visualized Experiments
- No. 223,p. e67872
A Murine Model of Carotid Aneurysm Formation
Cerebral aneurysms are present in approximately 2%-5% of the population and represent a significant public health concern due to their high rates of mortality and morbidity upon rupture. Despite advancements in research, the development of effective and reproducible animal models remains a challenge. Among the available models, surgically induced aneurysms are widely utilized; however, the technical complexity of these procedures often limits their accessibility. These methods require extensive surgical expertise and are associated with higher rates of intraoperative mortality or inconsistent aneurysm formation, which can compromise the reliability of experimental outcomes. To address these limitations, this video article introduces a simplified surgical procedure for inducing carotid aneurysms in mice, performed in a single session. This streamlined approach has demonstrated an impressive 87% success rate in inducing carotid aneurysms in female mice. By reducing technical challenges and improving reproducibility, this method provides a practical and reliable alternative for cerebral aneurysm research. Its widespread adoption could facilitate standardized studies, accelerate the development of therapeutic strategies, and ultimately advance our understanding of aneurysm pathophysiology.
- Open Access
- 30 March 2025
- Published by Elsevier in Biomaterials
- Vol. 321, 123299
Novel laser-textured grooves extended to the sidewall edges of CoCr surfaces for rapid and selective endothelialization following coronary artery stenting
- 30 March 2025
- Published by Elsevier in Biomaterials
- Vol. 321, 123299
Open AccessNovel laser-textured grooves extended to the sidewall edges of CoCr surfaces for rapid and selective endothelialization following coronary artery stenting
- Open Access
- 3 November 2024
- Published by Wiley in Advanced Healthcare Materials
- Vol. 14 (2) , e2402757
Intervening to Preserve Function in Ischemic Cardiomyopathy with a Porous Hydrogel and Extracellular Matrix Composite in a Rat Myocardial Infarction Model
Multiple hydrogels are developed for injection therapy after myocardial infarction, with some incorporating substances promoting tissue regeneration and others emphasizing mechanical effects. In this study, porosity and extracellular matrix‐derived digest (ECM) are incorporated, into a mechanically optimized, thermoresponsive, degradable hydrogel (poly(N‐isopropylacrylamide‐co‐N‐vinylpyrrolidone‐co‐MAPLA)) and evaluate whether this biomaterial injectate can abrogate adverse remodeling in rat ischemic cardiomyopathy. After myocardial infarction, rats are divided into four groups: NP (non‐porous hydrogel) without either ECM or porosity, PM (porous hydrogel) from the same synthetic copolymer with mannitol beads as porogens, and PME with porosity and ECM digest added to the synthetic copolymer. PBS injection alone is a control group. Intramyocardial injections occurred 3 days after myocardial infarction followed by serial echocardiography and histological assessments 8 weeks after infarction. Echocardiographic function and neovascularization improved in the PME group compared to the other hydrogels and PBS injection. The PME group also demonstrated improved LV geometry and macrophage polarization (toward M2) compared to PBS, whereas differences are not observed in the NP or PM groups versus control. These results demonstrate further functional improvement may be achieved in hydrogel injection therapy for ischemic cardiomyopathy by incorporating porosity and ECM digest, representing combined mechanical and biological effects.
- 3 November 2024
- Published by Wiley in Advanced Healthcare Materials
- Vol. 14 (2) , e2402757
Open AccessIntervening to Preserve Function in Ischemic Cardiomyopathy with a Porous Hydrogel and Extracellular Matrix Composite in a Rat Myocardial Infarction Model
Multiple hydrogels are developed for injection therapy after myocardial infarction, with some incorporating substances promoting tissue regeneration and others emphasizing mechanical effects. In this study, porosity and extracellular matrix‐derived digest (ECM) are incorporated, into a mechanically optimized, thermoresponsive, degradable hydrogel (poly(N‐isopropylacrylamide‐co‐N‐vinylpyrrolidone‐co‐MAPLA)) and evaluate whether this biomaterial injectate can abrogate adverse remodeling in rat ischemic cardiomyopathy. After myocardial infarction, rats are divided into four groups: NP (non‐porous hydrogel) without either ECM or porosity, PM (porous hydrogel) from the same synthetic copolymer with mannitol beads as porogens, and PME with porosity and ECM digest added to the synthetic copolymer. PBS injection alone is a control group. Intramyocardial injections occurred 3 days after myocardial infarction followed by serial echocardiography and histological assessments 8 weeks after infarction. Echocardiographic function and neovascularization improved in the PME group compared to the other hydrogels and PBS injection. The PME group also demonstrated improved LV geometry and macrophage polarization (toward M2) compared to PBS, whereas differences are not observed in the NP or PM groups versus control. These results demonstrate further functional improvement may be achieved in hydrogel injection therapy for ischemic cardiomyopathy by incorporating porosity and ECM digest, representing combined mechanical and biological effects.
- Open Access
- 13 July 2024
- Published by American Chemical Society (ACS) in Biomacromolecules
- Vol. 25 (8) , 4879-4890
Development of an Injectable, ECM-Derivative Embolic for the Treatment of Cerebral Saccular Aneurysms
Cerebral aneurysms are a source of neurological morbidity and mortality, most often as a result of rupture. The most common approach for treating aneurysms involves endovascular embolization using nonbiodegradable medical devices, such as platinum coils. However, the need for retreatment due to the recanalization of coil-treated aneurysms highlights the importance of exploring alternative solutions. In this study, we propose an injectable extracellular matrix-derived embolic formed in situ by Michael addition of gelatin-thiol (Gel-SH) and hyaluronic acid vinyl sulfone (HA-VS) that may be delivered with a therapeutic agent (here, RADA-SP) to fill and remodel aneurysmal tissue without leaving behind permanent foreign bodies. The injectable embolic material demonstrated rapid gelation under physiological conditions, forming a highly porous structure and allowing for cellular infiltration. The injectable embolic exhibited thrombogenic behavior in vitro that was comparable to that of alginate injectables. Furthermore, in vivo studies in a murine carotid aneurysm model demonstrated the successful embolization of a saccular aneurysm and extensive cellular infiltration both with and without RADA-SP at 3 weeks, with some evidence of increased vascular or fibrosis markers with RADA-SP incorporation. The results indicate that the developed embolic has inherent potential for acutely filling cerebrovascular aneurysms and encouraging the cellular infiltration that would be necessary for stable, chronic remodeling.
- 13 July 2024
- Published by American Chemical Society (ACS) in Biomacromolecules
- Vol. 25 (8) , 4879-4890
Open AccessDevelopment of an Injectable, ECM-Derivative Embolic for the Treatment of Cerebral Saccular Aneurysms
Cerebral aneurysms are a source of neurological morbidity and mortality, most often as a result of rupture. The most common approach for treating aneurysms involves endovascular embolization using nonbiodegradable medical devices, such as platinum coils. However, the need for retreatment due to the recanalization of coil-treated aneurysms highlights the importance of exploring alternative solutions. In this study, we propose an injectable extracellular matrix-derived embolic formed in situ by Michael addition of gelatin-thiol (Gel-SH) and hyaluronic acid vinyl sulfone (HA-VS) that may be delivered with a therapeutic agent (here, RADA-SP) to fill and remodel aneurysmal tissue without leaving behind permanent foreign bodies. The injectable embolic material demonstrated rapid gelation under physiological conditions, forming a highly porous structure and allowing for cellular infiltration. The injectable embolic exhibited thrombogenic behavior in vitro that was comparable to that of alginate injectables. Furthermore, in vivo studies in a murine carotid aneurysm model demonstrated the successful embolization of a saccular aneurysm and extensive cellular infiltration both with and without RADA-SP at 3 weeks, with some evidence of increased vascular or fibrosis markers with RADA-SP incorporation. The results indicate that the developed embolic has inherent potential for acutely filling cerebrovascular aneurysms and encouraging the cellular infiltration that would be necessary for stable, chronic remodeling.
- Open Access
Intervening to preserve function in ischemic cardiomyopathy with a porous hydrogel and extracellular matrix composite in a rat myocardial infarction model
A variety of hydrogels have been developed for intramyocardial injection therapy after myocardial infarction. Some of these biomaterials have incorporated bioactive substances that promote local tissue regeneration and integration, while others have emphasized the mechanical role of the injectate in providing functional benefit. In this study, we incorporated two bioactive features, porosity, and extracellular matrix derived hydrogel (ECM), into a mechanically optimized, thermoresponsive, degradable hydrogel (poly(N-isopropylacrylamide-co-N-vinylpyrrolidone-co-MAPLA) copolymer) and evaluated whether injection of this biomaterial could abrogate the remodeling process in a rat ischemic cardiomyopathy model. After myocardial infarction by coronary artery ligation, rats were randomly divided into four groups: group NP (non-porous hydrogel) without either ECM or porosity, group PM (porous hydrogel) from the same synthetic copolymer with mannitol beads as porogens, and group PME with porosity and ECM digest added to the synthetic copolymer. A group with PBS injection alone served as a control. Intramyocardial injections were made 3 days after myocardial infarction. Serial echocardiography was assessed over time, and histological assessments were performed eight weeks after infarction. Results demonstrated improved echocardiographic function and neovascularization in the PME group compared to the other hydrogels and PBS injection. The PME group also demonstrated significant improvement in LV geometry and macrophage polarization (towards M2) compared to the PBS group, whereas these differences were not observed in the NP or PM groups versus the control. These results demonstrate that further functional improvement may be achieved in hydrogel injection therapy for ischemic cardiomyopathy by incorporating porosity and ECM digest, representing a combination of mechanical and biological effects.
Open AccessIntervening to preserve function in ischemic cardiomyopathy with a porous hydrogel and extracellular matrix composite in a rat myocardial infarction model
A variety of hydrogels have been developed for intramyocardial injection therapy after myocardial infarction. Some of these biomaterials have incorporated bioactive substances that promote local tissue regeneration and integration, while others have emphasized the mechanical role of the injectate in providing functional benefit. In this study, we incorporated two bioactive features, porosity, and extracellular matrix derived hydrogel (ECM), into a mechanically optimized, thermoresponsive, degradable hydrogel (poly(N-isopropylacrylamide-co-N-vinylpyrrolidone-co-MAPLA) copolymer) and evaluated whether injection of this biomaterial could abrogate the remodeling process in a rat ischemic cardiomyopathy model. After myocardial infarction by coronary artery ligation, rats were randomly divided into four groups: group NP (non-porous hydrogel) without either ECM or porosity, group PM (porous hydrogel) from the same synthetic copolymer with mannitol beads as porogens, and group PME with porosity and ECM digest added to the synthetic copolymer. A group with PBS injection alone served as a control. Intramyocardial injections were made 3 days after myocardial infarction. Serial echocardiography was assessed over time, and histological assessments were performed eight weeks after infarction. Results demonstrated improved echocardiographic function and neovascularization in the PME group compared to the other hydrogels and PBS injection. The PME group also demonstrated significant improvement in LV geometry and macrophage polarization (towards M2) compared to the PBS group, whereas these differences were not observed in the NP or PM groups versus the control. These results demonstrate that further functional improvement may be achieved in hydrogel injection therapy for ischemic cardiomyopathy by incorporating porosity and ECM digest, representing a combination of mechanical and biological effects.
- Top Cited PapersOpen Access
- 6 February 2024
- Published by Springer Nature in Nature Communications
- Vol. 15 (1) , 1-12
Shape-recovery of implanted shape-memory devices remotely triggered via image-guided ultrasound heating
Shape-memory materials hold great potential to impart medical devices with functionalities useful during implantation, locomotion, drug delivery, and removal. However, their clinical translation is limited by a lack of non-invasive and precise methods to trigger and control the shape recovery, especially for devices implanted in deep tissues. In this study, the application of image-guided high-intensity focused ultrasound (HIFU) heating is tested. Magnetic resonance-guided HIFU triggered shape-recovery of a device made of polyurethane urea while monitoring its temperature by magnetic resonance thermometry. Deformation of the polyurethane urea in a live canine bladder (5 cm deep) is achieved with 8 seconds of ultrasound-guided HIFU with millimeter resolution energy focus. Tissue sections show no hyperthermic tissue injury. A conceptual application in ureteral stent shape-recovery reduces removal resistance. In conclusion, image-guided HIFU demonstrates deep energy penetration, safety and speed.
- 6 February 2024
- Published by Springer Nature in Nature Communications
- Vol. 15 (1) , 1-12
Top Cited PapersOpen AccessShape-recovery of implanted shape-memory devices remotely triggered via image-guided ultrasound heating
Shape-memory materials hold great potential to impart medical devices with functionalities useful during implantation, locomotion, drug delivery, and removal. However, their clinical translation is limited by a lack of non-invasive and precise methods to trigger and control the shape recovery, especially for devices implanted in deep tissues. In this study, the application of image-guided high-intensity focused ultrasound (HIFU) heating is tested. Magnetic resonance-guided HIFU triggered shape-recovery of a device made of polyurethane urea while monitoring its temperature by magnetic resonance thermometry. Deformation of the polyurethane urea in a live canine bladder (5 cm deep) is achieved with 8 seconds of ultrasound-guided HIFU with millimeter resolution energy focus. Tissue sections show no hyperthermic tissue injury. A conceptual application in ureteral stent shape-recovery reduces removal resistance. In conclusion, image-guided HIFU demonstrates deep energy penetration, safety and speed.
- Open Access
A Novel Low-Profile Self-Expanding Biodegradable Percutaneous Heart Valve Frame That Grows with a Child
According to rough estimates, one in every 125 newborns born in the United States has a congenital cardiac abnormality that must be repaired. With the recent development of new biomaterials and innovative treatment methods, percutaneous cardiac valve replacement has been considered as an alternative to surgical procedures. While percutaneous heart valve replacement is a relatively new procedure with a few commercially available devices, the devices are not sufficiently low-profile, and do not grow with the child. To address this issue, a novel low-profile growing percutaneous pediatric heart valve frame made of two types of unique metallic biomaterials (supere lastic nitinol and biodegradable iron) has been developed through this study. The developed pediatric heart valve frame has an innovative mechanism that will expand its diameter by disconnecting biodegradable metals, enabling the growth of the device with the surrounding tissue in the cardiac space. The thermally treated iron wires show stable and gradual degradation characteristics, showing approximately 7.66% for both wires treated under 350 and 450 °C. Polymer-coated wires show a degradation range of 4.96 to 5.55% depending on the type of coating. Degradation test results show the predicted 9–23 months of degradation depending on the type of surface treatment (e.g., thermal treatment, polymer coating), which is a suitable range when compared with the theoretical arterial vessel remodeling process period in the human vascular system. Radial forces calculated by finite element analysis and measured by mechanical testing matched well, showing 5–6 N with a 20% diameter reduction considering the deployed valve frame in the heart. Biocompatibility study results demonstrated superior cell viability in thermally treated iron wires after 3 days of cell culture and showed rarely found platelets on the surface after 3-h blood exposure tests. Prototype devices were successfully fabricated using optimized advanced joining processes for dissimilar metallic materials such as nitinol and iron. This study represents the first demonstration of self-expanding and biodegradable percutaneous heart valve frames for pediatric patients that grow with a child.
Open AccessA Novel Low-Profile Self-Expanding Biodegradable Percutaneous Heart Valve Frame That Grows with a Child
According to rough estimates, one in every 125 newborns born in the United States has a congenital cardiac abnormality that must be repaired. With the recent development of new biomaterials and innovative treatment methods, percutaneous cardiac valve replacement has been considered as an alternative to surgical procedures. While percutaneous heart valve replacement is a relatively new procedure with a few commercially available devices, the devices are not sufficiently low-profile, and do not grow with the child. To address this issue, a novel low-profile growing percutaneous pediatric heart valve frame made of two types of unique metallic biomaterials (supere lastic nitinol and biodegradable iron) has been developed through this study. The developed pediatric heart valve frame has an innovative mechanism that will expand its diameter by disconnecting biodegradable metals, enabling the growth of the device with the surrounding tissue in the cardiac space. The thermally treated iron wires show stable and gradual degradation characteristics, showing approximately 7.66% for both wires treated under 350 and 450 °C. Polymer-coated wires show a degradation range of 4.96 to 5.55% depending on the type of coating. Degradation test results show the predicted 9–23 months of degradation depending on the type of surface treatment (e.g., thermal treatment, polymer coating), which is a suitable range when compared with the theoretical arterial vessel remodeling process period in the human vascular system. Radial forces calculated by finite element analysis and measured by mechanical testing matched well, showing 5–6 N with a 20% diameter reduction considering the deployed valve frame in the heart. Biocompatibility study results demonstrated superior cell viability in thermally treated iron wires after 3 days of cell culture and showed rarely found platelets on the surface after 3-h blood exposure tests. Prototype devices were successfully fabricated using optimized advanced joining processes for dissimilar metallic materials such as nitinol and iron. This study represents the first demonstration of self-expanding and biodegradable percutaneous heart valve frames for pediatric patients that grow with a child.
- 17 October 2022
- Published by Elsevier in Biomaterials
- Vol. 290, 121857
Bioabsorbable, elastomer-coated magnesium alloy coils for treating saccular cerebrovascular aneurysms
- 17 October 2022
- Published by Elsevier in Biomaterials
- Vol. 290, 121857
Bioabsorbable, elastomer-coated magnesium alloy coils for treating saccular cerebrovascular aneurysms